| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Contineum Therapeutics, Inc. | Director | Stock Option (right to buy) | 14,750 | 26 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CTNM | Contineum Therapeutics, Inc. | 26 Jun 2025 | 1 | $0 | 4 | Director | 26 Jun 2025, 17:46 |
| CTNM | Contineum Therapeutics, Inc. | 24 May 2024 | 1 | $0 | 4 | Director | 29 May 2024, 17:54 |
| CTNM | Contineum Therapeutics, Inc. | 04 Apr 2024 | 0 | $0 | 3 | Director | 04 Apr 2024, 17:56 |